Molecular mechanisms of metastatic peritoneal dissemination in gastric adenocarcinoma

Pastushenko, I., & Blanpain, C. (2019). EMT transition states during tumor progression and metastasis. Trends in Cell Biology, 29(3), 212–226.

Article  PubMed  Google Scholar 

Hippo, Y., et al. (2001). Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes. Cancer Research, 61(3), 889–895.

PubMed  Google Scholar 

Bai, F. H., et al. (2012). Screening and identification of peritoneal metastasis-related genes of gastric adenocarcinoma using a cDNA microarray. Genetics & Molecular Research, 11(2), 1682–1689.

Article  Google Scholar 

Kanda, M., & Kodera, Y. (2016). Molecular mechanisms of peritoneal dissemination in gastric cancer. World Journal of Gastroenterology, 22(30), 6829–6840.

Article  PubMed  PubMed Central  Google Scholar 

Rau, B., et al. (2020). Peritoneal metastasis in gastric cancer: Results from the German database. Gastric Cancer, 23(1), 11–22.

Article  PubMed  Google Scholar 

Koemans, W. J., et al. (2021). Synchronous peritoneal metastases of gastric cancer origin: Incidence, treatment and survival of a nationwide Dutch cohort. Gastric Cancer, 24(4), 800–809.

Article  PubMed  Google Scholar 

Lee, J. E., et al. (2023). Genomic and evolutionary characteristics of metastatic gastric cancer by routes. British Journal of Cancer, 129(4), 672–682.

Article  PubMed  PubMed Central  Google Scholar 

Ren, K., et al., Development of the peritoneal metastasis: A review of back-grounds, mechanisms, treatments and prospects. J Clin Med, 2022. 12(1).

Yonemura, Y., et al., The development of peritoneal metastasis from gastric cancer and rationale of treatment according to the mechanism. J Clin Med, 2022. 11(2).

Cristescu, R., et al. (2015). Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes. Nature Medicine, 21(5), 449–456.

Article  PubMed  Google Scholar 

Bai, F., et al. (2007). Establishment and characterization of a high metastatic potential in the peritoneum for human gastric cancer by orthotopic tumor cell implantation. Digestive Diseases and Sciences, 52(6), 1571–1578.

Article  PubMed  Google Scholar 

Wang, R., et al. (2020). Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response. Gut, 69(1), 18–31.

Article  PubMed  Google Scholar 

Bai, F., et al. (2007). Establishment and characterization of a high metastatic potential in the peritoneum for human gastric cancer by orthotopic tumor cell implantation. Digestive Diseases & Sciences, 52(6), 1571–1578.

Article  Google Scholar 

Li, F., et al. (2018). S100A4-MYH9 axis promote migration and invasion of gastric cancer cells by inducing TGF-beta-mediated epithelial-mesenchymal transition. Journal of Cancer, 9(21), 3839–3849.

Article  PubMed  PubMed Central  Google Scholar 

Yonemura, Y., et al. (2000). Inverse expression of S100A4 and E-cadherin is associated with metastatic potential in gastric cancer. Clinical Cancer Research, 6(11), 4234–4242.

PubMed  Google Scholar 

Pan, T., et al. (2021). Tumor suppressor lnc-CTSLP4 inhibits EMT and metastasis of gastric cancer by attenuating HNRNPAB-dependent Snail transcription. Mol Ther Nucleic Acids, 23, 1288–1303.

Article  PubMed  PubMed Central  Google Scholar 

Kurashige, J., et al. (2015). Epigenetic modulation and repression of miR-200b by cancer-associated fibroblasts contribute to cancer invasion and peritoneal dissemination in gastric cancer. Carcinogenesis, 36(1), 133–141.

Article  PubMed  Google Scholar 

Jiang, T., et al., FNDC1 promotes the invasiveness of gastric cancer via Wnt/beta-catenin signaling pathway and correlates with peritoneal metastasis and prognosis. Frontiers in Oncology, 2020. 10 (no pagination).

Sasahara, M., et al. (2021). Tissue RNFT2 expression levels are associated with peritoneal recurrence and poor prognosis in gastric cancer. Anticancer Research, 41(2), 609–617.

Article  PubMed  Google Scholar 

Sawaki, K., et al. (2018). Troponin I2 as a specific biomarker for prediction of peritoneal metastasis in gastric cancer. Annals of Surgical Oncology, 25(7), 2083–2090.

Article  PubMed  Google Scholar 

Shimura, T., et al. (2021). Genomewide expression profiling identifies a novel miRNA-based signature for the detection of peritoneal metastasis in patients with gastric cancer. Annals of Surgery, 274(5), e425–e434.

Article  PubMed  Google Scholar 

Zang, M., et al. (2014). CEACAM6 promotes gastric cancer invasion and metastasis by inducing epithelial-mesenchymal transition via PI3K/AKT signaling pathway. PLoS ONE, 9(11), e112908.

Article  PubMed  PubMed Central  Google Scholar 

Takei, Y., et al. (2020). Long noncoding RNA HOTAIR promotes epithelial-mesenchymal transition and is a suitable target to inhibit peritoneal dissemination in human scirrhous gastric cancers. Pathobiology, 87(5), 277–290.

Article  PubMed  Google Scholar 

Yu, Z., et al. (2019). Oncostatin M receptor, positively regulated by SP1, promotes gastric cancer growth and metastasis upon treatment with Oncostatin M. Gastric Cancer, 22(5), 955–966.

Article  PubMed  Google Scholar 

Wang, X., et al. (2021). Piezo type mechanosensitive ion channel component 1 facilitates gastric cancer omentum metastasis. Journal of Cellular & Molecular Medicine, 25(4), 2238–2253.

Article  Google Scholar 

Wang, X., et al. (2021). Piezo type mechanosensitive ion channel component 1 facilitates gastric cancer omentum metastasis. Journal of Cellular and Molecular Medicine, 25(4), 2238–2253.

Article  PubMed  PubMed Central  Google Scholar 

Peng, Z., et al. (2014). Role of epithelial-mesenchymal transition in gastric cancer initiation and progression. World Journal of Gastroenterology, 20(18), 5403–5410.

Article  PubMed  PubMed Central  Google Scholar 

Zhang, D. Z., et al. (2017). Basic transcription factor 3 is required for proliferation and epithelial-mesenchymal transition via regulation of FOXM1 and JAK2/STAT3 signaling in gastric cancer. Oncology Research, 25(9), 1453–1462.

Article  PubMed  PubMed Central  Google Scholar 

Wu, X., et al. (2017). IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2/STAT3 signaling pathway. Oncotarget, 8(13), 20741–20750.

Article  PubMed  PubMed Central  Google Scholar 

Kim, M. A., et al. (2009). Prognostic importance of epithelial-mesenchymal transition-related protein expression in gastric carcinoma. Histopathology, 54(4), 442–451.

Article  PubMed  Google Scholar 

Ge, Q., et al. (2020). Zic1 suppresses gastric cancer metastasis by regulating Wnt/β-catenin signaling and epithelial-mesenchymal transition. The FASEB Journal, 34(2), 2161–2172.

Article  PubMed  Google Scholar 

Wu, S., et al. (2017). AEG-1 induces gastric cancer metastasis by upregulation of eIF4E expression. Journal of Cellular and Molecular Medicine, 21(12), 3481–3493.

Article  PubMed  PubMed Central  Google Scholar 

Carino, A., et al. (2016). The bile acid receptor GPBAR1 (TGR5) is expressed in human gastric cancers and promotes epithelial-mesenchymal transition in gastric cancer cell lines. Oncotarget, 7(38), 61021–61035.

Article  PubMed  PubMed Central  Google Scholar 

Toiyama, Y., et al., Use of co-expression of HGF and c-Met to predict peritoneal dissemination established by autocrine HGF/c-Met signaling in gastric cancer. Journal of Clinical Oncology. Conference, 2011. 29(4 SUPPL. 1).

Zhou, Q., et al. (2020). The reciprocal interaction between tumor cells and activated fibroblasts mediated by TNF-alpha/IL-33/ST2L signaling promotes gastric cancer metastasis. Oncogene, 39(7), 1414–1428.

Article  PubMed  Google Scholar 

Chen, B., et al., H. pylori-induced NF-κB-PIEZO1-YAP1-CTGF axis drives gastric cancer progression and cancer-associated fibroblast-mediated tumour microenvironment remodelling. Clin Transl Med, 2023. 13(11): p. e1481.

Zhang, Z., et al. (2020). A research of STEAP1 regulated gastric cancer cell proliferation, migration and invasion in vitro and in vivos. Journal of Cellular and Molecular Medicine, 24(24), 14217–14230.

Article  PubMed  PubMed Central  Google Scholar 

Jiang, J., et al. (2011). IRX1 influences peritoneal spreading and metastasis via inhibiting BDKRB2-dependent neovascularization on gastric cancer. Oncogene, 30(44), 4498–4508.

Article  PubMed  PubMed Central  Google Scholar 

Tokuyama, J., et al. (2005). Tyrosine kinase inhibitor SU6668 inhibits peritoneal dissemination of gastric cancer via suppression of tumor angiogenesis. Anticancer Research, 25(1A), 17–22.

PubMed 

Comments (0)

No login
gif